Emerging risks | Growth Opportunities | APAC Insurance

Monday, January 12, 2026

Emerging risks | Growth opportunities | APAC insurance

Monday, 12 January 2026

Dedicated hubs

Browse content

AXA, China Biotech Services sign MoU to explore cancer treatment option for policyholders

Partnership aims to bring together AXA’s insurance expertise and China Biotech Services’ focus on precision diagnostics and therapeutics.
Axa china biotech services sign mou to explore cancer treatment option for policyholders  rein asia

Stay ahead with precise, independent journalism of APAC's insurance markets.


Experience 7 days of full access to premium insights

Already a member?

Login here

Share this article

Read next